Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen
- 22 April 2004
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 61 (4) , 318-323
- https://doi.org/10.1002/pros.20087
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- ClusterinThe International Journal of Biochemistry & Cell Biology, 2002
- Acquisition of Resistance to Fas-Mediated Apoptosis by Overexpression of Clusterin in Human Renal-Cell Carcinoma CellsMolecular Urology, 2001
- Overexpression of Insulin-Like Growth Factor Binding Protein-5 Helps Accelerate Progression to Androgen-Independence in the Human Prostate LNCaP Tumor Model through Activation of Phosphatidylinositol 3′-Kinase Pathway*Endocrinology, 2000
- Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative propertiesKidney International, 1998
- Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotypeThe Prostate, 1998
- Expression of antioxidant enzymes in human prostatic adenocarcinomaThe Prostate, 1997
- Prooxidant-Antioxidant Shift Induced by Androgen Treatment of Human Prostate Carcinoma CellsJNCI Journal of the National Cancer Institute, 1997
- Age and Racial Distribution of Prostatic Intraepithelial NeoplasiaEuropean Urology, 1996
- Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death.Journal of Clinical Investigation, 1994
- SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosisKidney International, 1991